The settlement of matters dating back more than a decade will see the Anglo-Swedish drugmaker pay a net amount of $1.1 billion to resolve all U.S. transfer pricing issues -- less than the amount it had set aside in provisions.
via reuters.com
The settlement of matters dating back more than a decade will see the Anglo-Swedish drugmaker pay a net amount of $1.1 billion to resolve all U.S. transfer pricing issues -- less than the amount it had set aside in provisions.
No comments:
Post a Comment